文献速递消化内镜消化道肿瘤与早癌

内镜下胃体折叠术治疗肥胖:新技术操作成功与安全性

Endoscopic gastric body plication for the treatment of obesity: technical success and safety of a novel technique (with video).
PubMed 文献 · Gastrointest Endosc · 2020-01-28

本研究为初步研究,评估一种仅折叠胃体、保留胃底的新型内镜下减重手术(POSE)的可行性、安全性和疗效。10例肥胖患者接受远端POSE,技术成功率100%,严重不良事件率0%,6个月总体重减轻15.0%±7.1%,高血压、糖尿病、GERD和阻塞性睡眠呼吸暂停均有改善。

要点

  • 新型远端POSE仅折叠胃体、保留胃底,技术成功率100%。
  • 严重不良事件率0%,6个月总体重减轻15.0%±7.1%。
  • 所有患者达到至少5%总体重减轻,80%达到至少25%多余体重减轻。

核心结论

  • 新型远端POSE手术聚焦胃体折叠并保留胃底,技术上可行,对肥胖治疗似乎安全有效。

研究设计与样本

  • 初步研究纳入10例接受远端POSE胃体折叠术的肥胖患者,其中女性6例,年龄52±20岁,基线BMI为38.1±6.2 kg/m2。

主要发现

  • 技术成功率为100%,每例平均放置21±4个折叠。
  • 严重不良事件率为0%。
  • 6个月时总体重减轻为15.0%±7.1%。
  • 所有患者达到至少5%总体重减轻,8例(80%)达到至少25%多余体重减轻。
  • 术后高血压、糖尿病、GERD和阻塞性睡眠呼吸暂停均有改善。

临床怎么用

  • 该技术可为肥胖患者提供一种保留胃底、仅折叠胃体的内镜减重选择,需进一步研究验证。

局限性

  • 本研究为初步研究,样本量仅10例,缺乏对照和长期随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Primary obesity surgery endoluminal (POSE) is a primary endoscopic bariatric therapy focusing on gastric remodeling. The original POSE procedure involved placement of full-thickness plications in the fundus. Here we aim to assess the feasibility, safety, and efficacy of a novel POSE procedure that involves plications of only the gastric body to reduce the width and length of the stomach. METHODS: This was a pilot study of patients who underwent a distal POSE procedure with gastric body plications for the treatment of obesity. Outcomes included technical success rate, serious adverse event (AE) rate, and efficacy of this novel POSE procedure at inducing weight loss and improving obesity-related comorbidities. RESULTS: Ten patients (6 women, age 52 ± 20 years) underwent a distal POSE procedure. Baseline body mass index was 38.1 ± 6.2 kg/m2. The technical success rate was 100%. An average of 21 ± 4 plications were placed per case (6 ± 2 for distal belt, 10 ± 3 for suspenders, 4 ± 2 for proximal belt, and 3 ± 1 for fillers). The gastroesophageal junction was pulled distally by 3.0 ± 1.6 cm. The gastric body was shortened by 11.0 ± 5.1 cm, representing a 59% reduction. The serious AE rate was 0%. At 6 months, patients experienced 15.0% ± 7.1% total weight loss (TWL). All patients achieved at least 5% TWL, and 8 patients (80%) achieved at least 25% excess weight loss. Hypertension, diabetes, GERD, and obstructive sleep apnea improved after the procedure. CONCLUSIONS: This novel POSE procedure, focusing on gastric body plication and sparing the fundus, is technically feasible and appears to be safe and effective for the treatment of obesity.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Jirapinyo P, Thompson CC. Endoscopic gastric body plication for the treatment of obesity: technical success and safety of a novel technique (with video). Gastrointest Endosc. 2020. PMID: 32001332. doi:10.1016/j.gie.2020.01.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。